Heparin therapy in giant cell arteritis

被引：22
作者：
Buono, LM
Foroozan, R
de Virgiliis, M
Savino, PJ
机构：
[1] Duke Univ, Ctr Eye, Neuroophthalmol Serv, Durham, NC 27710 USA
[2] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Houston, TX 77030 USA
[3] Hosp Pedro Lagleyze, Dept Ophthalmol, Buenos Aires, DF, Argentina
[4] Thomas Jefferson Univ, Jefferson Med Coll, Wills Eye Hosp, Neuroophthalmol Serv, Philadelphia, PA 19107 USA
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 2004年 / 88卷 / 02期
关键词：
D O I：
10.1136/bjo.2003.021592
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：298 / 301
页数：4
相关论文
共 16 条
  • [1] ORBITAL COLOR DOPPLER IMAGING
    ABURN, NS
    SERGOTT, RC
    [J]. EYE, 1993, 7 : 639 - 647
  • [2] AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550
  • [3] Steroid management in giant cell arteritis
    Chan, CCK
    Paine, M
    O'Day, J
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (09) : 1061 - 1064
  • [4] Progressive visual loss from giant cell arteritis despite high dose intravenous methylprednisolone
    Cornblath, WT
    Eggenberger, ER
    [J]. OPHTHALMOLOGY, 1997, 104 (05) : 854 - 858
  • [5] Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells
    Garg, HG
    Thompson, BT
    Hales, CA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (05) : L779 - L789
  • [6] González-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO
  • [7] 2-Z
  • [8] Levesque H, 1993, Eur J Med, V2, P186
  • [9] LIEB WE, 1992, ACTA OPHTHALMOL, V70, P50
  • [10] Risk factors for visual loss in giant cell (Temporal) arteritis: A prospective study of 174 patients
    Liozon, E
    Herrmann, F
    Ly, K
    Robert, PY
    Loustaud, V
    Soria, P
    Vidal, E
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (03) : 211 - 217
12